{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-016982","form_type":"8-K","ticker":"MTVA","cik":"0001638287","company_name":"MetaVia Inc.","filed_at":"2023-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.899256+00:00","generated_at":"2026-06-09T06:02:44.230374+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"NeuroBo Pharmaceuticals appoints Marshall H. Woodworth as Acting CFO effective Oct 27, 2023","bullets":["Marshall H. Woodworth appointed Acting CFO, Principal Financial and Principal Accounting Officer, effective October 27, 2023.","Woodworth previously served as CFO of Nevakar Inc. (2017-2023), Braeburn Pharmaceuticals, and Furiex Pharmaceuticals.","Compensation: $375 per hour paid to WhiteCap Search Holdings LLC under an engagement agreement; no family relationships or material interests.","Woodworth entered a Proprietary Information and Invention Assignment Agreement with NeuroBo; no other arrangements in connection with appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-016982","json":"https://secwatch.observer/filing/0001558370-23-016982.json","markdown":"https://secwatch.observer/filing/0001558370-23-016982.md","text":"https://secwatch.observer/filing/0001558370-23-016982.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638287/000155837023016982/0001558370-23-016982-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638287/000155837023016982/nrbo-20231025x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T06:02:44.230374+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d55ac9b10b","claim":"Marshall H. Woodworth was appointed as Acting Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer at MetaVia Inc..","evidence_excerpt":"On October 25, 2023, the Board of Directors (the “Board” ) of NeuroBo Pharmaceuticals, Inc. (the “Company” ) appointed Mr. Marshall H. Woodworth as the Company’s Acting Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective as of October 27, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1638287/000155837023016982/0001558370-23-016982-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Acting Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}